Eli V. Gelfand

1.1k total citations
33 papers, 680 citations indexed

About

Eli V. Gelfand is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Eli V. Gelfand has authored 33 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Surgery. Recurrent topics in Eli V. Gelfand's work include Cardiac Imaging and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Eli V. Gelfand is often cited by papers focused on Cardiac Imaging and Diagnostics (11 papers), Cardiac Valve Diseases and Treatments (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Eli V. Gelfand collaborates with scholars based in United States, Israel and Canada. Eli V. Gelfand's co-authors include Christopher P. Cannon, Warren J. Manning, Susan B. Yeon, Thomas H. Hauser, Lois Goepfert, Neil M. Rofsky, Sean G. Hughes, Raphaëlle Dumaine, Robert P. Giugliano and Elliot M. Antman and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Eli V. Gelfand

32 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli V. Gelfand United States	11	454	188	154	152	103	33	680
Mevlüt Koç Türkiye	14	373 0.8×	84 0.4×	144 0.9×	84 0.6×	26 0.3×	87	615
Csaba Lengyel Hungary	15	519 1.1×	152 0.8×	214 1.4×	70 0.5×	23 0.2×	80	937
DRJ Singer United Kingdom	13	226 0.5×	59 0.3×	83 0.5×	73 0.5×	16 0.2×	33	466
Jonathan Rubin United States	11	444 1.0×	194 1.0×	155 1.0×	122 0.8×	13 0.1×	18	732
Hanne Elming Denmark	16	748 1.6×	73 0.4×	62 0.4×	57 0.4×	14 0.1×	37	951
Daniele Massera United States	17	510 1.1×	151 0.8×	129 0.8×	170 1.1×	6 0.1×	58	755
Anoosh Esmaeili Germany	12	155 0.3×	59 0.3×	166 1.1×	198 1.3×	19 0.2×	32	538
Chris Pepper United Kingdom	15	439 1.0×	75 0.4×	81 0.5×	63 0.4×	13 0.1×	30	628
Masatsugu Iwase Japan	16	621 1.4×	253 1.3×	139 0.9×	55 0.4×	14 0.1×	52	749
Yong‐Hyun Kim South Korea	14	374 0.8×	107 0.6×	93 0.6×	71 0.5×	8 0.1×	59	592

Countries citing papers authored by Eli V. Gelfand

Since Specialization

Citations

This map shows the geographic impact of Eli V. Gelfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli V. Gelfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli V. Gelfand more than expected).

Fields of papers citing papers by Eli V. Gelfand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli V. Gelfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli V. Gelfand. The network helps show where Eli V. Gelfand may publish in the future.

Co-authorship network of co-authors of Eli V. Gelfand

This figure shows the co-authorship network connecting the top 25 collaborators of Eli V. Gelfand. A scholar is included among the top collaborators of Eli V. Gelfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli V. Gelfand. Eli V. Gelfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gelfand, Eli V., et al.. (2025). Lipoprotein(a) – From Biomarker to Therapy: A Review for the Clinician. The American Journal of Cardiology. 245. 42–53. 5 indexed citations

Diamond, Jamie, Michael Mi, Paul A. VanderLaan, Louis M. Chu, & Eli V. Gelfand. (2021). An Unusual Cause of Functional Mitral Stenosis. SHILAP Revista de lepidopterología. 3(5). 829–833. 2 indexed citations

Strom, Jordan B., et al.. (2020). Relation of Transthoracic Echocardiographic Aortic Regurgitation to Pressure Half-time and All-Cause Mortality. The American Journal of Cardiology. 135. 113–119. 1 indexed citations

Steinhaus, Daniel A., Eli V. Gelfand, Paul A. VanderLaan, & Robb D. Kociol. (2014). Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support. The Journal of Heart and Lung Transplantation. 33(7). 769–771. 10 indexed citations

Anter, Elad, Joshua R. Silverstein, Cory M. Tschabrunn, et al.. (2014). Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 11(11). 1890–1897. 55 indexed citations

Brinkley, D. Marshall & Eli V. Gelfand. (2013). Valvular Heart Disease: Classic Teaching and Emerging Paradigms. The American Journal of Medicine. 126(12). 1035–1042. 21 indexed citations

Gelfand, Eli V., et al.. (2012). Care of Patients With Apparently Asymptomatic Severe Aortic Valve Stenosis. Clinical Cardiology. 35(12). E29–34. 1 indexed citations

Tamez, Hector & Eli V. Gelfand. (2010). Lyme Disease Masquerading as Acute Coronary Syndrome. Infectious Diseases in Clinical Practice. 19(4). 293–296. 1 indexed citations

Gelfand, Eli V., Thomas H. Hauser, Susan B. Yeon, et al.. (2010). Predictors of preserved left ventricular systolic function after surgery for chronic organic mitral regurgitation: a prospective study.. PubMed. 19(1). 43–50. 10 indexed citations

10.

Gelfand, Eli V., et al.. (2009). Cardiovascular magnetic resonance imaging for valvular heart disease. Current Heart Failure Reports. 6(3). 160–166. 6 indexed citations

11.

Appelbaum, Evan, Ajay J. Kirtane, Yuri B. Pride, et al.. (2008). Association of TIMI Myocardial Perfusion Grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. 27(2). 123–129. 23 indexed citations

12.

Gelfand, Eli V. & Christopher P. Cannon. (2007). Myocardial infarction: contemporary management strategies. Journal of Internal Medicine. 262(1). 59–77. 10 indexed citations

13.

Gelfand, Eli V., et al.. (2007). Rimonabant: The role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients. Current Atherosclerosis Reports. 9(5). 359–366. 2 indexed citations

14.

Gelfand, Eli V. & Christopher P. Cannon. (2006). Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors. Expert Opinion on Investigational Drugs. 15(3). 307–315. 51 indexed citations

15.

Gelfand, Eli V. & Christopher P. Cannon. (2006). Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors. Journal of the American College of Cardiology. 47(10). 1919–1926. 89 indexed citations

16.

Gelfand, Eli V., Sean G. Hughes, Thomas H. Hauser, et al.. (2006). Severity of Mitral and Aortic Regurgitation as Assessed by Cardiovascular Magnetic Resonance: Optimizing Correlation with Doppler Echocardiography. Journal of Cardiovascular Magnetic Resonance. 8(3). 503–507. 189 indexed citations

17.

Dumaine, Raphaëlle, Eli V. Gelfand, Sabina A. Murphy, et al.. (2004). Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials. European Heart Journal. 25(22). 1998–2005. 117 indexed citations

18.

Gelfand, Eli V. & Christopher P. Cannon. (2004). Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT. American Heart Journal. 147(2). 202–209. 16 indexed citations

19.

Gelfand, Eli V., Gregory Piazza, & Samuel Z. Goldhaber. (2003). Venous Thromboembolism Guidebook, Fourth Edition. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 2(4). 247–265. 5 indexed citations

20.

Gelfand, Eli V., Gregory Piazza, & Samuel Z. Goldhaber. (2002). Venous Thromboembolism Guidebook. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 1(1). 26–43. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact